| Literature DB >> 29699542 |
Zheng Wang1, Qi-Zhe Cai2, Cheng-Jun Ban1, Duo Chen1, Li-Li Xu1, Xiao-Juan Wang1, Zhen Wang1, Yuan Yang1, Xiu-Zhang Lv2, Huan-Zhong Shi3.
Abstract
BACKGROUND: Pleural effusion (PE) drainage can relieve the symptoms of dyspnea; however, details of the resulting hemodynamic changes remain undefined.Entities:
Keywords: Drainage; Hemodynamic; Large-volume pleural effusion; Transthoracic echocardiography
Mesh:
Year: 2018 PMID: 29699542 PMCID: PMC5921556 DOI: 10.1186/s12890-018-0625-5
Source DB: PubMed Journal: BMC Pulm Med ISSN: 1471-2466 Impact factor: 3.317
Subjects’ characteristics
| Variables | Total | Lateral of effusion, n (%) | ||
|---|---|---|---|---|
| Left | Right | |||
| Subjects, n(%) | 47 (100.0) | 23 (48.9) | 24 (51.1) | |
| Gender, n (%) | ||||
| Female | 18 (38.3) | 5 (21.7) | 13 (54.2) | 0.022 |
| Male | 29 (61.7) | 18 (78.3) | 11 (45.8) | |
| Age, yr., mean ± SD | 56.4 ± 19.5 | 52.6 ± 19.0 | 63.1 ± 17.3 | 0.726 |
| BSA, mean ± SD | 1.73 ± 0.19 | 1.83 ± 0.16 | 1.63 ± 0.17 | 0.582 |
| Smoking status, n (%) | ||||
| Current or previous smoker | 18 (38.3) | 6 (26.1) | 12 (50.0) | 0.092 |
| Non-smoker | 29 (61.7) | 17 (73.9) | 12 (50.0) | |
| Past history | ||||
| Tuberculosis | 4 (8.5) | 3 (13.0) | 1 (4.2) | 0.546 |
| Malignancy | 4 (8.5) | 2 (8.7) | 2 (8.3) | |
| NA | 39 (83.0) | 18 (78.3) | 21 (87.5) | |
| Size of effusion, n (%) | ||||
| Small | 8 (17.0) | 3 (13.0) | 5 (20.8) | 0.696 |
| Moderate | 9 (19.1) | 4 (17.4) | 5 (20.8) | |
| Large | 30 (63.9) | 16 (69.6) | 14 (58.3) | |
| volume of effusion, (ml) | ||||
| Total volume | 2142.2 ± 1393.7 | 2194.6 ± 1511.1 | 2203.6 ± 1301.8 | 0.827 |
| Immediate volume | 1414.4 ± 727.9 | 1384.8 ± 982.0 | 1495.2 ± 947.6 | 0.744 |
| 24 h volume | 943.6 ± 742.8 | 809.8 ± 787.2 | 708.4 ± 708.0 | 0.855 |
| Effusion appearance, n (%) | ||||
| Bloody | 20 (42.5) | 11 (47.8) | 9 (37.5) | 0.474 |
| Yellow | 27 (57.5) | 12 (52.2) | 15 (62.5) | |
| Operation | ||||
| IPC | 15 (31.9) | 8 (34.8) | 7 (29.2) | 0.893 |
| Thoracentesis | 10 (21.3) | 5 (21.7) | 5 (20.8) | |
| thoracoscopic | 22 (46.8) | 10 (43.5) | 12 (50.0) | |
| Pre Nt-pro-BNP (ng/ml) | 221.3 ± 316.5 | 126.7 ± 176.6 | 320.2 ± 396.5 | 0.004 |
Abbreviations: SD standard deviation, IPC indwelling pleural catheter
P*, Wilcoxon’s test or Pearson’s χ2 test, P < 0.05
Causes of pleural effusion
| Cause | n, % | |
|---|---|---|
| Malignancies | 24 (51.1) | |
| Primary lung cancer | 14 (29.8) | |
| Secondary carcinoma | 2 (4.3) | |
| Mesothelioma | 4 (8.5) | |
| Lymphoma | 1 (2.1) | |
| Undetermined | 3 (6.4) | |
| Benign diseases | 23 (48.9) | |
| Tuberculosis | 17 (36.0) | |
| Non-specific pleurisy | 2 (4.3) | |
| Other transudate | 2 (4.3) | |
| Other exudates | 2 (4.3) | |
| Total | 47 (100.0) |
Real-time echocardiographic changes in hemodynamics before and after pleural drainage
| Parameters | Effusion ( | |||||
|---|---|---|---|---|---|---|
| Before | Immediately After |
| 24 h After |
|
| |
| Left Heart | ||||||
| LVdVI, (ml/m2) | 31.9 (24.3–42.8) | 35.3 (31.3–44.9) | < 0.001 | 36.7 (31.1–48.2) | < 0.001 | 0.019 |
| LVsVI, (ml/m2) | 11.3 (9.4–16.7) | 12.2 (10.2–16.3) | 0.220 | 12.2 (10.3–15.2) | < 0.001 | 0.264 |
| LAVI, (ml/m2) | 22.8 (17.2–26.0) | 26.5 (19.1–29.7) | 0.018 | 27.4 (22.9–32.0) | < 0.001 | 0.234 |
| Right Heart | ||||||
| RV area, (cm2) | 14.1 (12.5–18.9) | 17.3 (15.2–18.9) | 0.036 | 17.3 (15.0–18.5) | 0.011 | 0.782 |
| RA area, (cm2) | 11.8 (9.9–14.9) | 14.1 (11.3–16.3) | 0.016 | 14.2 (11.3–15.6) | 0.018 | 0.727 |
| Left ventricle | ||||||
| LVEF, (%) | 62.0 (59.3–66.8) | 65.0 (63.0–68.8) | 0.030 | 68.5 (64.0–71.0) | 0.008 | 0.071 |
| SV, (ml) | 36.0 (27.3–47.5) | 41.0 (35.5–49.8) | < 0.001 | 42.5 (38.0–52.6) | < 0.001 | 0.006 |
| Sm, (cm/s) | 8.2 (7.5–9.7) | 8.0 (7.5–9.3) | 0.952 | 9.0 (8.0–9.6) | 0.137 | 0.055 |
| GLS, (%) | 19.0 (18.0–20.0) | 19.5 (18.0–21.0) | 0.086 | 21.0 (18.0–22.9) | < 0.001 | 0.029 |
| Right ventricle | ||||||
| FAC, (%) | 45.5 (38.3–52.0) | 48.0 (45.0–57.0) | 0.065 | 50.0 (40.0–55.0) | 0.347 | < 0.001 |
| TAPSE, (cm) | 18.0 (17.0–19.8) | 20.1 (19.0–22.0) | < 0.001 | 22.4 (19.5–24.8) | 0.001 | < 0.001 |
| RVFWs, (%) | 18.0 (17.6–19.3) | 19.1 (18.3–21.5) | 0.137 | 19.3 (18.3–21.1) | 0.018 | 0.603 |
| Left ventricle | ||||||
| IVRT, (s) | 106.0 (106.0–127.0) | 113.0 (106.0–123.0) | 0.601 | 118.0 (106.0–135.3) | 0.310 | 0.649 |
| E, (cm/s) | 74.5 (67.8–85.0) | 70.7 (64.3–76.8) | 0.285 | 64.8 (56.8–82.4) | 0.178 | 0.683 |
| A, (cm/s) | 85.5 (63.8–113.8) | 91.9 (58.7–103.3) | 0.493 | 80.8 (48.9–93.4) | 0.019 | 0.058 |
| E/A | 0.9 (0.7–1.1) | 0.8 (0.7–1.3) | 0.546 | 0.9 (0.7–1.3) | 0.260 | 0.157 |
| Em, (cm/s) | 7.0 (6.1–9.8) | 7.4 (6.3–8.7) | 0.819 | 8.4 (6.2–9.3) | 0.170 | 0.170 |
| Am, (cm/s) | 10.4 (8.9–11.7) | 10.9 (10.0–12.1) | 0.390 | 11.0 (10.4–12.6) | 0.334 | 0.309 |
| E/Em | 10.9 (7.1–13.6) | 9.8 (7.3–11.0) | 0.419 | 9.1 (6.4–10.6) | 0.023 | 0.095 |
| Right ventricle | ||||||
| MPI | 0.7 (0.6–0.7) | 0.5 (0.5–0.7) | < 0.001 | 0.5 (0.4–0.6) | 0.002 | 0.585 |
| TvE, (cm/s) | 54.0 (45.0–65.3) | 57.0 (50.3–65.9) | 0.536 | 53.0 (46.2–64.8) | 0.543 | 0.065 |
| TvA, (cm/s) | 51.5 (40.8–60.3) | 48.7 (40.8–60.3) | 1.000 | 41.8 (35.9–51.5) | 0.069 | 0.027 |
| TvE/A | 1.1 (0.8–1.3) | 1.2 (0.8–1.4) | 0.619 | 1.3 (1.1–1.4) | 0.122 | 0.265 |
| TvE/Et | 4.2 (3.6–5.8) | 4.5 (3.1–4.9) | 0.339 | 3.5 (2.8–5.4) | 0.264 | 0.406 |
Abbreviations: LVdVI Left ventricular end diastolic volume index, LVsVI left ventricular end-systolic volume index, LAVI left atrial volume index, RV area, right ventricular area, RA area, right atrial area, LVEF left ventricular ejection fraction, SV stroke volume, Sm systolic mitral annular velocity, GLS global left ventricular strain, FAC fractional area change, TAPSE, tricuspid annular plane systolic excursion, RVFWs right ventricular free-wall strain, E early-transmitralflow velocity, A late-transmitral flow velocity, E/A, ratio of early- to late-transmitral flow velocity, Em, early-diastolic mitral annular velocity, Am late-diastolic mitral annular velocity, E/Em ratio of early-transmitral flow velocity to diastolic mitral annular velocity, MPI, myocardial performance index, TvE early-transtricuspid flow velocity, TvA late-transtricuspid flow velocity;TvE/A, ratio of early- to late-transtricuspid flow velocity, TvE/Et, ratio of early-transtricuspid flow velocity to diastolic tricuspid annular velocity
*Pa < 0.05 compared with the corresponding parameters before and immediately after drainage; Pb < 0.05 compared with the corresponding parameters before and 24 h after drainage;Pc < 0.05 compared with the corresponding value immediately after drainage and the value 24 h after drainage
Fig. 1a–c shows the changes in LVdVI, stroke volume, and TAPSE at baseline, immediately after, and 24 h after drainage for the entire study population. d shows the changes instroke volume in the left- and right-sided effusion subgroups. LVdVI, left ventricular end diastolic volume index; SV, stroke volume; TAPSE, tricuspid annular plane systolic excursion